4.1 Article

Gabapentin initiation in the inpatient setting: A characterization of prescribing

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update

Kirk E. Evoy et al.

Summary: The studies confirm a rising trend of gabapentinoid misuse/abuse, leading to significant patient harm.

DRUGS (2021)

Article Pharmacology & Pharmacy

Current state of opioid stewardship

L. Diana Ardeljan et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)

Editorial Material Endocrinology & Metabolism

Diabetic Neuropathy: A Position Statement by the American Diabetes Association

Rodica Pop-Busui et al.

DIABETES CARE (2017)

Editorial Material Medicine, General & Internal

Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern?

Christopher W. Goodman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Medicine, General & Internal

CDC Guideline for Prescribing Opioids for Chronic Pain-United States, 2016

Deborah Dowell et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Health Care Sciences & Services

Evidence, regulation and 'rational' prescribing: the case of gabapentin for neuropathic pain

Narcyz Ghinea et al.

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2015)

Article Pharmacology & Pharmacy

Medication reconciliation at hospital discharge: Evaluating discrepancies

Jacqueline D. Wong et al.

ANNALS OF PHARMACOTHERAPY (2008)